ALLMedicine™ Trigeminal Neuralgia Center
Research & Reviews 1,204 results
https://doi.org/10.1007/s11916-022-01065-3 10.1097/PR9.0000000000000884 10.1177/1941874414535215 10.1016/S1474-4422(20)30109-5 10.1212/WNL.0000000000009619 10.1056/NEJMc2009191 10.2147/JPR.S274199 10.1002/mus.27083 10.1016/j.bbi.2020.05.025 10.1016/j.clineuro.2020.105921 10.1001/jamaneurol.2020.1065 10.12688/wellcomeopenres.15987.2 10.1016/j.trsl.2020.04.007 10.1021/acschemneuro.0c00122 10.1056/NEJMcp013211 10.1111/head.13884 10.1002/mus.26322
Current Pain and Headache Reports; Joshi D, Gyanpuri V et. al.
Jun 23rd, 2022 - Researchers suggests that patients with COVID-19 develop neuropathic pain within weeks or months following infection and that patients with neuropathic pain and COVID-19 sometimes present with deterioration of neurologic complications and pain exa...
https://clinicaltrials.gov/ct2/show/NCT05217628
Jun 21st, 2022 - This study is designed to evaluate the efficacy and safety of basimglurant in patients with TN. Basimglurant is a potent inhibitor of metabotropic glutamate receptor 5 (mGluR5) which controls a wide range of processes in both central and periphera...
https://doi.org/10.1007/s11916-022-01066-2 10.1212/WNL.0000000000002840 10.1002/ana.410270114 10.1177/0333102411424619 10.1093/brain/123.4.665 10.1111/head.12441 10.1007/s10072-005-0431-8 10.1016/j.pain.2014.04.020 10.1007/s11940-019-0583-0 10.1016/j.ejrad.2010.02.006 10.1126/science.150.3699.971 10.1046/j.1525-1403.1999.00150.x 10.1016/j.jpainsymman.2005.12.012 10.1227/01.neu.0000144839.65524.e0 10.1016/j.pain.2007.07.028 10.1016/j.jpainsymman.2005.12.010 10.1002/ana.10996 10.1016/0304-3959(95)00238-3 10.1016/s1078-5884(97)80174-8 10.1016/j.jpainsymman.2005.12.013 10.1053/ejvs.2002.1876 10.1159/000099978 10.1016/j.wneu.2018.03.044 10.1093/ons/opz381 10.1016/j.ijsu.2017.08.070
Current Pain and Headache Reports; Gupta M, Chitneni A et. al.
Jun 19th, 2022 - Trigeminal neuralgia (TN) is a chronic neuropathic pain condition affecting one or more divisions of the fifth cranial (trigeminal) nerve. TN is defined by recurrent unilateral electric shock-like pain that is abrupt in both onset and termination....
http://emedicine.medscape.com/article/1113663-overview
Jun 16th, 2022 - Practice Essentials Extracranial brain tissue without a direct connection to the brain itself may be an isolated cutaneous embryonic defect, usually on occipital or parietal areas of the scalp. It is also known as heterotopic brain tissue or cutan...
https://emedicine.medscape.com/article/1113663-overview
Jun 16th, 2022 - Practice Essentials Extracranial brain tissue without a direct connection to the brain itself may be an isolated cutaneous embryonic defect, usually on occipital or parietal areas of the scalp. It is also known as heterotopic brain tissue or cutan...
Guidelines 2 results
https://doi.org/10.1093/neuros/nyx512
Neurosurgery Hadjipanayis CG, Carlson ML et. al.
Jan 9th, 2018 - What surgical approaches for vestibular schwannomas (VS) are best for complete resection and facial nerve (FN) preservation when serviceable hearing is present? There is insufficient evidence to support the superiority of either the middle fossa (...
https://doi.org/10.1111/j.1533-2500.2009.00298.x
Pain Practice : the Official Journal of World Institute O... van Kleef M, van Genderen WE et. al.
Jul 22nd, 2009 - Trigeminal neuralgia is a common cause of facial pain. It has a significant impact on the quality of life and the socioeconomic functioning of the patient. The aim of this review is to provide recommendations for medical management of trigeminal n...
Drugs 43 results see all →
Clinicaltrials.gov 92 results
https://clinicaltrials.gov/ct2/show/NCT05217628
Jun 21st, 2022 - This study is designed to evaluate the efficacy and safety of basimglurant in patients with TN. Basimglurant is a potent inhibitor of metabotropic glutamate receptor 5 (mGluR5) which controls a wide range of processes in both central and periphera...
https://clinicaltrials.gov/ct2/show/NCT05411900
Jun 9th, 2022 - Botulinum toxin type A (BoNT-A) is widely used to treat muscle hyperactivity, based on its ability to inhibit synaptic exocytosis and, therefore, to disable neural transmission. Further research has shown that BoNT-A has analgesic properties indep...
https://clinicaltrials.gov/ct2/show/NCT05032573
Jun 7th, 2022 - Trigeminal neuralgia (TGN) pain is debilitating and unpredictable. Alleviation of intensity or frequency to any degree will improve the quality of life of the individuals affected. Current medical treatments for TGN are often not effective. In som...
https://clinicaltrials.gov/ct2/show/NCT02910323
May 25th, 2022 - The Will Erwin Headache Research Center will assemble a national registry of Cluster Headache patients and will sub-categorize and organize this cohort based on individuating characteristics including but not limited to type and severity of condit...
https://clinicaltrials.gov/ct2/show/NCT03941834
May 20th, 2022 - The purpose of this study is to evaluate the efficacy of BHV3000 compared to placebo for subjects with treatment refractory Trigeminal Neuralgia as measured by a 2-point or greater reduction in the average Numeric Pain Rating Scale between the two...
News 43 results
https://www.mdedge.com/neurology/msresourcecenter/article/250896/multiple-sclerosis/trigeminal-neuralgia-more-common-women
Jan 19th, 2022 - Key clinical point: Women presenting with multiple sclerosis (MS) are more likely to develop trigeminal neuralgia (TN) relative to men with MS. Major finding: The estimated pooled TN prevalence in the overall population was 3.
https://www.mdedge.com/familymedicine/article/248633/musculoskeletal-disorders/botulinum-toxin-chronic-pain-whats-horizon
MDedge Family Medicine; Caleb Dickison, DO, CAQSM, Jeffrey C. Leggit, MD, CAQSM
Nov 12th, 2021 - Botulinum toxin (BoNT) was first approved by the US Food and Drug Administration (FDA) for the treatment of strabismus and blepharospasm in 1989. Since then, approved indications have expanded to include spasticity, cervical dystonia, severe axill.
https://www.medscape.com/viewarticle/962892
Nov 12th, 2021 - NEW ORLEANS — Intraorbital frontal nerve resection appears effective for some patients with idiopathic trigeminal neuralgia where the ophthalmic division (V1) is involved, researchers say. The procedure offers long-term relief in a condition where...
https://www.mdedge.com/dermatology/article/234112/mixed-topics/unilateral-alar-ulceration
Patrick S. Phelan, MD, Zachary P. Nahmias, MD et. al.
Jan 5th, 2021 - The Diagnosis: Trigeminal Trophic Syndrome (Self-induced Trauma) The patient admitted to manipulation of the ala in response to persistent pain despite resolution of the herpes zoster, for which he recently had completed a course of oral acyclovir.
https://www.medscape.com/viewarticle/938374
Oct 1st, 2020 - The National Institute for Health and Care Excellence (NICE) has published updated recommendations on the management of neuropathic pain. Key recommendations are summarised below: Principles of care When agreeing a treatment plan with the person d...
